ArticleMolecular therapy. Oncology2026

Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studies.

Rachael Mooney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.